Vitamin D3 for Life

Live Enlightened

Article

What Circulating Vitamin D Levels Measure: Biomarker Status Versus Biological Effect: Full Study

Previous related pageVitamin D StorageNext related pageWhat Circulating Vitamin D Levels Measure: Biomarker Status Versus Biological Effect: Study Summary
Study at a glance

What does the usual vitamin D blood test measure?

This evidence review explains what a vitamin D blood test can tell us. The usual test measures 25-hydroxyvitamin D, often shortened to 25(OH)D. This is a form made mainly in the liver from vitamin D supplied by sunlight exposure, food and supplements. Its blood level is useful for assessing vitamin D supply. It does not directly measure everything vitamin D does in the body.

Why can vitamin D blood levels and effects differ?

Vitamin D must reach tissues and be changed into an active form before it can produce many of its effects. Cells also control how they respond to that active form and how quickly it is broken down. These processes can differ between tissues and people. The same blood level therefore does not prove that every tissue is responding in the same way.

Would a different blood test show every vitamin D effect?

No single blood measurement discussed here does that. Most 25(OH)D travels attached to proteins; a small amount travels freely. Measuring either amount still does not directly measure activity inside cells. The active form of vitamin D is tightly controlled in blood. Its blood level also does not show all the active vitamin D made and used within individual tissues.

What can a vitamin D blood result tell us about health?

The usual vitamin D test remains useful, despite these limits. A low result can indicate a reduced supply, while a higher result indicates more of the measured form in blood. Neither result alone measures health benefit or activity in every organ. A link between blood levels and health outcomes also does not prove that raising the level will improve those outcomes.

Read the full article below ↓

A circulating vitamin D level is a biomarker, not a direct reading of everything vitamin D is doing in the body. In routine assessment, the principal measurement is serum or plasma 25-hydroxyvitamin D [25(OH)D], which integrates vitamin D entering from skin synthesis, food and supplements and provides a practical measure of vitamin D status. Its concentration can therefore tell us something important about vitamin D supply, but it does not directly quantify calcium absorption, intracellular vitamin D activation, vitamin D receptor signalling, gene transcription or another downstream biological effect. This distinction is central to understanding What Vitamin D Levels Represent. For a shorter version of this evidence review, see What Circulating Vitamin D Levels Measure: Biomarker Status Versus Biological Effect: Study Summary.

25(OH)D is primarily a marker of vitamin D status

Vitamin D obtained from ultraviolet-B exposure, food or supplements is not itself the principal circulating marker used to judge vitamin D status. It is first hydroxylated, mainly in the liver, to form 25(OH)D. Compared with the active hormone 1,25-dihydroxyvitamin D [1,25(OH)₂D], 25(OH)D circulates at much higher concentrations and persists substantially longer. These properties make it more stable and practical as an indicator of vitamin D supply.

The distinction between vitamin D supply and vitamin D action begins here. A serum 25(OH)D concentration reflects the circulating pool generated from endogenous synthesis and intake, but the biological pathway continues beyond that measurement. 25(OH)D may subsequently be converted to 1,25(OH)₂D, delivered differently between tissues, regulated by endocrine and intracrine mechanisms and interpreted through vitamin D receptor-dependent cellular responses. A status biomarker therefore occupies one position in a longer physiological chain.

This is why Vitamin D Status vs Vitamin D Effect represents a genuine physiological distinction rather than a semantic one. Status describes the measurable state of vitamin D supply or its circulating metabolites. Effect describes what that supply ultimately produces biologically.

Why 25(OH)D became the standard status biomarker

Several features make 25(OH)D useful for status assessment. Its circulating concentration incorporates vitamin D derived from both skin and dietary sources. It responds to vitamin D intake, varies with environmental exposure and is sufficiently persistent in the circulation to provide a more informative status signal than the parent vitamin itself. Major clinical and nutritional frameworks have consequently used serum or plasma 25(OH)D as the principal biochemical indicator of vitamin D status.

Those strengths should not be mistaken for proof that 25(OH)D is a complete functional biomarker. Choosing the most practical marker of supply is a different scientific problem from identifying a measurement that directly represents every downstream tissue response. The fact that 25(OH)D is useful does not require it to perform both jobs.

The same distinction explains why Vitamin D Testing: 25-OH-D vs 1,25-OH₂-D treats the two major circulating metabolites separately. 25(OH)D is generally used to assess status, whereas circulating 1,25(OH)₂D is tightly regulated and answers a different physiological question. Replacing one with the other does not solve the broader problem of measuring tissue-level biological effect.

The pathway between circulating status and biological effect contains several regulated steps

For a circulating 25(OH)D molecule to contribute to a canonical vitamin D response, several events may still matter. The metabolite must be transported and made available to relevant tissues. It may require cellular uptake and conversion by CYP27B1 to 1,25(OH)₂D. The active metabolite then binds the vitamin D receptor, and the receptor participates with its molecular partners in regulating transcription. At the same time, CYP24A1 and other regulatory mechanisms can limit or terminate vitamin D metabolite activity.

These processes are not simply passive reflections of the serum 25(OH)D concentration. Renal activation is strongly regulated by mineral and endocrine physiology, while extrarenal activation can operate within tissue-specific environments. The broader pathway is developed in Vitamin D Activation and Vitamin D Metabolism at the Cellular Level.

This creates an important interpretation boundary. A blood concentration can describe the substrate available to the system without revealing the exact rate at which every tissue is activating that substrate, the amount of active hormone present within individual cells, the occupancy of VDR in those cells or the magnitude of the transcriptional response that follows.

Circulating 1,25(OH)₂D does not provide a simple functional answer either

It might appear that measuring 1,25(OH)₂D would solve the problem because it is the hormonally active metabolite. In practice, circulating 1,25(OH)₂D is tightly controlled by calcium, phosphate, parathyroid hormone, fibroblast growth factor 23 and renal function. Its blood concentration can therefore be maintained despite a relatively low 25(OH)D substrate pool and may sometimes rise as part of compensatory physiology.

Circulating 1,25(OH)₂D also does not reveal all local intracrine production. A tissue capable of converting 25(OH)D locally may generate and use 1,25(OH)₂D within a cellular microenvironment without that local process being represented proportionally in the systemic blood concentration. This is one reason Vitamin D and Intracrine Activity must remain distinct from ordinary serum status assessment.

Transport and binding alter what a total concentration represents

Most circulating 25(OH)D is bound to vitamin D-binding protein, with a smaller proportion bound to albumin and only a very small fraction circulating freely. Total serum 25(OH)D measures these fractions together. That remains clinically useful, but it means the numerical result is a measurement of a circulating pool rather than a direct measurement of the quantity entering each tissue.

Under many ordinary circumstances, total and free 25(OH)D correlate strongly. The relationship can nevertheless shift when vitamin D-binding protein or albumin biology changes. This is why Free vs Total Vitamin D Explained and the deeper free-versus-total evidence pages treat binding state as an additional interpretive dimension rather than declaring total 25(OH)D either biologically complete or clinically useless.

The crucial point is that free, bioavailable and total measures remain circulating biomarkers. Even if one measurement better represents tissue availability in a particular circumstance, that would not automatically make it a direct measurement of receptor activation, gene regulation or clinical effect.

Tissue biology can separate substrate availability from response

Vitamin D action depends on more than substrate reaching the blood. Different tissues vary in the expression and regulation of CYP27B1, CYP24A1, VDR and other components of the signalling system. Local cellular state, inflammatory signals, endocrine conditions and tissue-specific regulatory architecture can therefore influence what happens downstream from the same circulating substrate concentration.

The presence of VDR throughout many tissues establishes broad biological capacity for vitamin D signalling, but receptor presence is not itself equivalent to a quantitatively identical response in every tissue. The receptor must participate in a functional signalling environment, and transcriptional responses depend on cellular and genomic context. The distinction between circulating substrate and downstream response therefore remains relevant even when the vitamin D pathway is intact.

Readers following that mechanistic layer can continue to Vitamin D Receptors and Vitamin D Signalling Pathways. Those pages address machinery that a serum 25(OH)D result does not directly measure.

A biomarker can be useful without being a direct causal readout

This distinction is common across physiology. A biomarker may be strongly informative because it tracks an important biological state while remaining separated by several mechanisms from the final outcome of interest. Serum 25(OH)D performs exactly this kind of job. It provides information about vitamin D status and substrate availability but does not collapse the complete pathway from exposure to tissue response into one number.

That does not weaken the legitimacy of vitamin D testing. It clarifies what the result can and cannot establish. A low value can indicate a depleted or reduced circulating 25(OH)D pool. A higher value indicates a larger circulating pool. Neither observation alone measures the exact magnitude of vitamin D-dependent biological activity in every organ.

Observed associations do not convert 25(OH)D into a direct effect marker

Another source of confusion arises when serum 25(OH)D correlates with a health outcome. Such a relationship may be scientifically meaningful, but an association between a circulating biomarker and an outcome is not the same as demonstrating that the biomarker directly measures the biological mechanism producing that outcome.

Circulating 25(OH)D is influenced by sun exposure, diet, supplementation, body composition, season, health state and other characteristics. Many of those factors can themselves relate to health outcomes. Randomised intervention evidence is therefore required when the question moves from association to whether deliberately changing vitamin D exposure changes a particular outcome. This is one reason the website separates physiological interpretation from broader claims about health effects.

Measurement variability adds another layer without changing the underlying principle

Even the circulating biomarker itself is not perfectly fixed. 25(OH)D can vary with season, recent exposure, supplementation pattern and biological state, while laboratory methods can introduce additional analytical variation. Standardisation programmes have substantially improved comparability, but the existence of assay variation reinforces the need to interpret a concentration as a measured biomarker rather than as an exact meter of tissue activity.

Variability in Vitamin D Measurements examines this distinction directly. Measurement variability and biological-function variability are not identical problems: one concerns how accurately and reproducibly the circulating quantity is measured; the other concerns how completely that circulating quantity represents subsequent physiology.

Why normal status and identical biological effect are not equivalent propositions

A person can have a serum 25(OH)D result that falls within a conventionally accepted status range without that test proving that every vitamin D-dependent process is operating identically to another person’s. Conversely, the existence of individual physiological variation does not mean that ordinary status assessment has no value. These are different propositions and should not be forced into an all-or-nothing choice.

Population thresholds can identify concentrations associated with defined nutritional or skeletal interpretations, but they do not establish a universal quantitative map from one serum value to every downstream biological response. This distinction becomes particularly important when moving from deficiency prevention to proposed functional targets.

For that next interpretive layer, Vitamin D Thresholds vs Targets separates the question of avoiding inadequacy from the much stronger claim that a particular circulating concentration maximises biological function.

What the evidence supports

The evidence supports several conclusions simultaneously. Serum or plasma 25(OH)D is the established principal biomarker of vitamin D status. It reflects vitamin D derived from skin synthesis and intake and provides clinically useful information about the circulating substrate pool. It should not, however, be interpreted as a direct assay of intracellular calcitriol production, VDR activation, gene transcription or the total biological effect of vitamin D throughout the body.

The evidence also does not justify reversing that conclusion into the claim that 25(OH)D is meaningless. Its limitations are boundaries around interpretation, not reasons to discard the biomarker. Nor does the evidence establish that another single circulating metabolite universally solves the status-versus-function problem. Free 25(OH)D, total 25(OH)D and 1,25(OH)₂D each describe different aspects of vitamin D physiology and must be interpreted according to the question being asked.

The practical physiological model

The most defensible model is a chain rather than a single number. Exposure and intake influence vitamin D supply. Hepatic metabolism contributes to the circulating 25(OH)D pool. Transport proteins shape its distribution in blood. Renal and extrarenal CYP27B1 can activate substrate under different regulatory conditions. CYP24A1 participates in metabolic control and clearance. Active vitamin D interacts with VDR, and receptor-dependent signalling produces tissue-specific molecular responses. Clinical outcomes sit still farther downstream.

A serum 25(OH)D result is informative because it measures an important part of that chain. It becomes misleading only when it is asked to represent the whole chain. The distinction between biomarker status and biological effect therefore preserves, rather than diminishes, the scientific value of vitamin D measurement.

Primary scientific sources

  • Cashman KD et al. 25-Hydroxyvitamin D as a Biomarker of Vitamin D Status and Its Modeling to Inform Strategies for Prevention of Vitamin D Deficiency within the Population.
  • Jones G. Assessment and Interpretation of Circulating 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D in the Clinical Environment.
  • Bikle DD. Nonclassic Actions of Vitamin D.
  • Chun RF et al. Vitamin D Binding Protein and the Biological Activity of Vitamin D.
  • Sempos CT et al. Analytical Considerations for the Biochemical Assessment of Vitamin D Status.
  • Giustina A et al. Consensus Statement on Vitamin D Status Assessment and Supplementation: Whys, Whens, and Hows.

Related reading

Original sources

Source

25-Hydroxyvitamin D as a Biomarker of Vitamin D Status and Its Modeling to Inform Strategies for Prevention of Vitamin D Deficiency within the Population

Cashman KD et al. 25-Hydroxyvitamin D as a Biomarker of Vitamin D Status and Its Modeling to Inform Strategies for Prevention of Vitamin D Deficiency within the Population.

Publication details

Cashman KD et al. 25-Hydroxyvitamin D as a Biomarker of Vitamin D Status and Its Modeling to Inform Strategies for Prevention of Vitamin D Deficiency within the Population.

Read more →